Scales & measures

Our measures are available to anyone who wishes to use them: for non-commercial users, the scales are free of charge; for commercial users, a fee is payable. If you are a non-commercial user, we just ask that you register your use of the scale(s) and if you are a commercial user, you will need to complete a brief user agreement. This is important to ensure:

  • you access the latest, most appropriate (e.g. language, culture) and authorised version of the measure and scoring guidelines
  • we can track all uses of the scales and their translations, to protect the integrity of the measures, and guide development of new languages, user tools and information guidelines
  • there is no unauthorised use, alteration or translation of the questionnaire, and no breach of copyright.

Permission will not be granted for any unauthorised modification or translation. Any analyses or publications of unauthorised versions may not use the scale name and may be considered a violation of copyright protection.

Diabetes Stigma Assessment Scale – Type 1 diabetes (DSAS-1)

The Type 1 Diabetes Stigma Assessment Scale (DSAS-1) is a self-report measures of perceived and experienced stigma related to living with type 1 diabetes. It is intended for self-completion by adults with type 1 diabetes, which takes approximately 2-5 minutes. The ACBRD holds the copyright for the original scale and any subsequent modified or translated versions.

The DSAS-1 includes 19 items, which form three sub-scales: Treated Differently, Blame and Judgement, Identity Concerns. A total scale score can also be calculated. Each sub-scale can be used independent of the others, but this will give an incomplete assessment of perceived and experienced stigma. We recommend use of the full 19 items, with analyses of total scale and sub-scales.

The DSAS-1 is currently available in English (for Australia) and Danish (for Denmark). Use in other cultural or linguistic groups would require appropriate adaptation. Other adaptations are underway, so please enquire about the latest versions.

To use the DSAS-1 in a non-commercial project or clinical practice, you will need to register to gain access to the latest authorised version. Download the Non-Commercial Registration Form, read the instructions, complete Appendix 1 (and Appendix 2 if relevant), and email it us: info@acbrd.org.au

To use the DSAS-1 in a commercially-funded project, download and complete the Commercial User Information Request, Then, email your Request to us (info@acbrd.org.au) to enable a Commercial Agreement to be drawn up.

Publications about the DSAS-1:

Browne JL, Ventura AD, Oliver K, Speight J (2017) Measuring type 1 diabetes stigma: development and validation of the Type 1 Diabetes Stigma Assessment Scale (DSAS-1). Diabetic Medicine, 34(12): 1773-1782

Møller Hansen UM, Willaing I, Ventura AD, Olesen K, Speight J, Browne JL. Stigma perceived and experienced by adults with type 1 diabetes: Linguistic adaptation and psychometric validation of the Danish version of the Type 1 Diabetes Stigma Assessment Scale (DSAS-1 DK). The Patient, 11(4): 403-412



Diabetes Stigma Assessment Scale – Type 2 diabetes (DSAS-2)

The Type 2 Diabetes Stigma Assessment Scale (DSAS-2) is a self-report measures of perceived and experienced related to living with type 2 diabetes. It is intended for self-completion by adults with type 2 diabetes, which takes approximately 2-5 minutes. The ACBRD holds the copyright for the original scale and any subsequent modified or translated versions.

The DSAS-2 includes 19 items, which form three sub-scales: Treated Differently, Blame and Judgement, Self-Stigma. A total scale score can also be calculated. Each sub-scale can be used independent of the others, but this will give an incomplete assessment of perceived and experienced stigma. We recommend use of the full 19 items, with analyses of total scale and sub-scales.

The DSAS-2 is currently available in English (for Australia). Use in other cultural or linguistic groups would require appropriate adaptation. Other adaptations are underway, so please enquire about the latest versions.

To use the DSAS-2 in a non-commercial project or clinical practice, you will need to register to gain access to the latest authorised version. Download the Non-Commercial Registration Form read the instructions, complete Appendix 1 (and Appendix 2 if relevant), and email it us: info@acbrd.org.au

To use the DSAS-2 in a commercially-funded project, download and complete the Commercial User Information Request. Then, email your Request to us (info@acbrd.org.au) to enable a Commercial Agreement to be drawn up.

Publications about the DSAS-2:

Browne JL, Ventura A, Oliver K, Speight J (2016) Measuring the stigma surrounding type 2 diabetes: development and validation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2). Diabetes Care, 39(12): 2141-2148

Holmes-Truscott E, Browne JL, Ventura AD, Pouwer F, Speight J. Is diabetes stigma associated with negative treatment appraisals among adults with insulin-treated type 2 diabetes? Results from the second Diabetes MILES – Australia (MILES-2) survey. Diabetic Medicine, 2018; 35(5): 658-662